Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care ...

On Thursday’s episode of Mad Money, Jim Cramer voiced his exasperation over the skepticism surrounding AI infrastructure as ...

Pathos AI has launched a $400 million funding round and already raised nearly $283 million. The Chicago-based startup formed ...

Tempus AI is a leader in applying AI solutions to cancer diagnosis. The company announced a new platform for speeding up the ...

On CNBC's "Mad Money Lightning Round," Jim Cramer recommended buying BlackRock, Inc. because "it's going to be a great position." ...

Clearfield County is a small step closer to being able to sue the architect and contractors who made a critical error in the design and construction of the county prison, which opened in 1981. That ...

BlackRock, Tempus, Sunrun, EXL Service, Union Pacific and VieMed Healthcare.

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Tempus Ai wasn’t one of them. The 10 stocks that made the cut could ...

ADMA Biologics, Inc. (NASDAQ: ADMA) (“ADMA” or the “Company”) recently announced U.S. FDA approval of its innovative yield enhancement production process. This innovative process has demonstrated an ...

Tempus Publishes Study Validating the Benefits of xF+, its Comprehensive Liquid Biopsy Assay for Therapy Selection ...

In fact, stock traders on social media follow Nancy Pelosi's stock trades closely due to the strong returns she and her husband, financier Paul Pelosi, have generated on certain trades. Here are Nancy ...

Tempus AI, Inc. TEM is scheduled to report first-quarter fiscal 2025 results on May 6. In the last reported quarter, the company’s adjusted loss of 18 cents was wider than the Zacks Consensus Estimate ...